Gleave ME - Search Results

1

LIN28B promotes the development of neuroendocrine prostate cancer.

Lovnicki J, Gan Y, Feng T, Li Y, Xie N, Ho CH, Lee AR, Chen X, Nappi L, Han B, Fazli L, Huang J, Gleave ME, Dong X. Lovnicki J, et al. Among authors: gleave me. J Clin Invest. 2020 Oct 1;130(10):5338-5348. doi: 10.1172/JCI135373. J Clin Invest. 2020. PMID: 32634132 Free PMC article.

2

Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.

Zellweger T, Chi K, Miyake H, Adomat H, Kiyama S, Skov K, Gleave ME. Zellweger T, et al. Among authors: gleave me. Clin Cancer Res. 2002 Oct;8(10):3276-84. Clin Cancer Res. 2002. PMID: 12374699

3

Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.

Kiyama S, Morrison K, Zellweger T, Akbari M, Cox M, Yu D, Miyake H, Gleave ME. Kiyama S, et al. Among authors: gleave me. Cancer Res. 2003 Jul 1;63(13):3575-84. Cancer Res. 2003. PMID: 12839944

4

Regulation of tumor angiogenesis by integrin-linked kinase (ILK).

Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S. Tan C, et al. Cancer Cell. 2004 Jan;5(1):79-90. doi: 10.1016/s1535-6108(03)00281-2. Cancer Cell. 2004. PMID: 14749128 Free article.

5

Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

July LV, Beraldi E, So A, Fazli L, Evans K, English JC, Gleave ME. July LV, et al. Among authors: gleave me. Mol Cancer Ther. 2004 Mar;3(3):223-32. Mol Cancer Ther. 2004. PMID: 15026542

6

YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.

Giménez-Bonafé P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S, Gleave ME, Nelson CC. Giménez-Bonafé P, et al. Among authors: gleave me. Prostate. 2004 May 15;59(3):337-49. doi: 10.1002/pros.20023. Prostate. 2004. PMID: 15042610

7

Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.

Rocchi P, So A, Kojima S, Signaevsky M, Beraldi E, Fazli L, Hurtado-Coll A, Yamanaka K, Gleave M. Rocchi P, et al. Cancer Res. 2004 Sep 15;64(18):6595-602. doi: 10.1158/0008-5472.CAN-03-3998. Cancer Res. 2004. PMID: 15374973

8

Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.

Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME. Krueckl SL, et al. Among authors: gleave me. Cancer Res. 2004 Dec 1;64(23):8620-9. doi: 10.1158/0008-5472.CAN-04-2446. Cancer Res. 2004. PMID: 15574769

9

Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate.

Knudsen BS, Lucas JM, Fazli L, Hawley S, Falcon S, Coleman IM, Martin DB, Xu C, True LD, Gleave ME, Nelson PS, Ayala GE. Knudsen BS, et al. Among authors: gleave me. Am J Pathol. 2005 Jul;167(1):255-66. doi: 10.1016/S0002-9440(10)62970-7. Am J Pathol. 2005. PMID: 15972969 Free PMC article.

10

Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.

Eigl BJ, Eggener SE, Baybik J, Ettinger S, Chi KN, Nelson C, Wang Z, Gleave ME. Eigl BJ, et al. Among authors: gleave me. Clin Cancer Res. 2005 Jul 1;11(13):4905-11. doi: 10.1158/1078-0432.CCR-04-2140. Clin Cancer Res. 2005. PMID: 16000589 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters